Mauna Kea Technologies has obtained FDA clearance for its updated Cellvizio endomicroscopy system for the GI and pulmonary tracts, according to a company release.
New features of the new Cellvizio 100 Series include improvements in endomicroscopic image acquisition and interpretation.
Used mainly in gastroenterology applications, Cellvizio provides real-time microscopic images of tissue inside the body.
Related Articles on FDA Clearances:
St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System
B. Braun Receives FDA 510(k) Clearance for New DUPLEX System Use
FDA OKs Covidien's Parietex Optimized Composite for Hernia Repair